E2F1 and hepatocellular carcinoma: As expected, the ECAR, glucose consumption rate, and the lactate production rate assays consistently revealed that E2F1 overexpression solidly reversed the status of low‐energy metabolism in CASC11‐silenced HCC cells (Figure 6E‐G).